IGC Pharma, Inc.
IGC· NYSE
IGCIGC Pharma, Inc.
Filed Jul 15, 2014 · 10-K · 106 days after period end · 0001185185-14-001804
derived · Computed from the longer spans the company filed.
| Metric | Q4 2014dderived from reported figures | Q4 2010dderived from reported figures |
|---|---|---|
| Revenue | — | $779.82K |
| Net Income | -$1.46M | -$17.04M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
IGC Pharma, Inc. · CIK 1326205 · Engraved from SEC EDGAR
ended Mar 31, 2014 · filed Jul 15, 2014 · 106 d after period end
